Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac^®) in chronic immune thrombocytopenic purpura

By Aledort L. M.   Salama A.   Kovaleva L.   Robak T.   Newland A. C.   Nugent D. J.   Brenner B.   Zenker O.  

Hematology, Vol. 12, Iss. 4, 2007-08 ,pp. : 289-295

Maney Publishing

Access to resources Recommend Favorite

Efficacy and safety of a new intravenous immunoglobulin 10% formulation (octagam^® 10%) in patients with immune thrombocytopenia

By Robak Tadeusz   Mainau Claudia   Pyringer Barbara   Chojnowski Krzysztof   Warzocha Krzysztof   Dmoszynska Anna   Straub Jan   Imbach Paul  

Hematology, Vol. 15, Iss. 5, 2010-10 ,pp. : 351-359

Maney Publishing

Access to resources Recommend Favorite

Intravenous Immunoglobulin G and Anti-D as Therapeutic Interventions in Immune Thrombocytopenic Purpura

By Blanchette FRCP V.   Carcao MD F.  

Transfusion and Apheresis Science, Vol. 19, Iss. 3, 1998-09 ,pp. : 279-288

Elsevier

Access to resources Recommend Favorite

Intravenous Immunoglobulin G and Anti-D as Therapeutic Interventions in Immune Thrombocytopenic Purpura

By Blanchette FRCP V.   Carcao MD F.  

Transfusion Science, Vol. 19, Iss. 3, 1998-09 ,pp. : 279-288

Elsevier

Access to resources Recommend Favorite

Management of children with acute and chronic immune thrombocytopenic purpura

By Kuhne M.   Imbach M.  

Transfusion and Apheresis Science, Vol. 19, Iss. 3, 1998-09 ,pp. : 261-268

Elsevier

Access to resources Recommend Favorite